Study: NCT01018979

Adverse event: HOSPITALIZATION FOR BONE MARROW TRANSPLANTATION
Serious: yes
Organ System: Surgical and medical procedures
Notes: Post-treatment SAE. Definitely not related to study drug
Frequency: 1 affected / 7 at risk

Adverse event: AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
Serious: yes
Organ System: Surgical and medical procedures
Notes: Post-treatment SAE. Definitely not related to study drug
Frequency: 1 affected / 7 at risk

Adverse event: Abdominal pain
Serious: no
Organ System: Gastrointestinal disorders
Notes: Post-treatment AE. Probably related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: ABNORMAL DATA OF INCREASE BILIRUBIN
Serious: no
Organ System: Investigations
Notes: Post-treatment AE. Probably not related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: Chest discomfort
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Notes: Post-treatment AE. Probably not related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: CLONIC OF RIGHT KNEE
Serious: no
Organ System: Nervous system disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Post-treatment AE. 1 probably related and 1 definitely related.
Frequency: 1 affected / 7 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Post-treatment AE. 2 definitely not related and 1 possible related.
Frequency: 2 affected / 7 at risk

Adverse event: Hypercalcaemia
Serious: no
Organ System: Metabolism and nutrition disorders
Notes: Post-treatment AE. All possible related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: HYPOCALCIUM
Serious: no
Organ System: Metabolism and nutrition disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: Hypokalaemia
Serious: no
Organ System: Metabolism and nutrition disorders
Notes: Post-treatment AE. Probably not related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: HYPOTENSION BP 82/51MMHG
Serious: no
Organ System: Vascular disorders
Notes: Post-treatment AE. Possible related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: HYPOVOLEMIC HYPOTENSION BP 78/56MMHG
Serious: no
Organ System: Vascular disorders
Notes: Post-treatment AE. Possible related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: INCREASE ALANINE AMINOTRANS-FERASE
Serious: no
Organ System: Investigations
Notes: Post-treatment AE. Probably not related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: INCREASE ALPHA-GANNA GLUTAMYL TRANSPEPTIDASE
Serious: no
Organ System: Investigations
Notes: Post-treatment AE. Probably not related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: Leukocytosis
Serious: no
Organ System: Blood and lymphatic system disorders
Notes: Post-treatment Ae. 3 possible related and 2 probably related.
Frequency: 2 affected / 7 at risk

Adverse event: MILD ABDOMINAL PAIN
Serious: no
Organ System: Gastrointestinal disorders
Notes: Post-treatment AE. Probably related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: MILD DIARRHEA
Serious: no
Organ System: Gastrointestinal disorders
Notes: Post-treatment AE. Probably related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: MILD DIZZINESS
Serious: no
Organ System: Nervous system disorders
Notes: Post-treatment AE. Possible related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: MILD HEADACHE
Serious: no
Organ System: Nervous system disorders
Notes: Post-treatment AE. Possible related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Post-treatment AE. Probably related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: NUMBNESS OF FACE AND PALM
Serious: no
Organ System: Nervous system disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: NUMBNESS OF FACE HANDS AND LEGS
Serious: no
Organ System: Nervous system disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: NUMBNESS OF LEGS AND LIPS
Serious: no
Organ System: Nervous system disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: NUMBNESS OF LIPS
Serious: no
Organ System: Nervous system disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 7 at risk

Adverse event: ADMISSION FOR PREPARATION OF PERIPHERAL BLOOD STEM CELL HARVEST
Serious: yes
Organ System: Surgical and medical procedures
Notes: Post-treatment SAE. Definitely not related to study drug
Frequency: 3 affected / 12 at risk

Adverse event: AUTOLOGOUS STEM CELL TRANSPLANT
Serious: yes
Organ System: Surgical and medical procedures
Notes: Post-treatment SAE. Definitely not related to study drug
Frequency: 1 affected / 12 at risk

Adverse event: TREATMENT OF NON-HODGKIN LYMPHOMA
Serious: yes
Organ System: Surgical and medical procedures
Notes: Post-treatment SAE. Definitely not related to study drug
Frequency: 1 affected / 12 at risk

Adverse event: PEIPHERAL BLOOD STEM CELL HARVEST
Serious: yes
Organ System: Surgical and medical procedures
Notes: Post-treatment SAE. Definitely not related to study drug
Frequency: 1 affected / 12 at risk

Adverse event: CARDIAC DISORDERS-OTHER:QT PROLONG AT 24HR-36HR AFTER INFUSION
Serious: no
Organ System: Investigations
Notes: Post-treatment AE. Possible related to study drug.
Frequency: 1 affected / 12 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Post-treatment AE. 1 probably related and 1 definitely related.
Frequency: 1 affected / 12 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Notes: Post-treatment AE. 2 definitely not related and 1 possible related.
Frequency: 1 affected / 12 at risk

Adverse event: Cough
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Notes: Post-treatment AE. Definitely not related.
Frequency: 1 affected / 12 at risk

Adverse event: ECCHYMOSIS OVER FEMORAL PUNCTURE SITE
Serious: no
Organ System: General disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 12 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 12 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Notes: Post-treatment AE. Possible related to study drug.
Frequency: 1 affected / 12 at risk

Adverse event: Hypertension
Serious: no
Organ System: Vascular disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 12 at risk

Adverse event: Hypocalcaemia
Serious: no
Organ System: Metabolism and nutrition disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 12 at risk

Adverse event: Hypokalaemia
Serious: no
Organ System: Metabolism and nutrition disorders
Notes: Post-treatment AE. Probably not related to study drug.
Frequency: 1 affected / 12 at risk

Adverse event: Hypotension
Serious: no
Organ System: Vascular disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 12 at risk

Adverse event: Pruritus
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Post-treatment AE. Probably not related to study drug.
Frequency: 1 affected / 12 at risk

Adverse event: Leukocytosis
Serious: no
Organ System: Blood and lymphatic system disorders
Notes: Post-treatment Ae. 3 possible related and 2 probably related.
Frequency: 2 affected / 12 at risk

Adverse event: Back pain
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Notes: Post-treatment AE. Probably related to study drug.
Frequency: 1 affected / 12 at risk

Adverse event: NUMBNESS OF FACE
Serious: no
Organ System: Nervous system disorders
Notes: Post-treatment AE. Definitely not related to study drug.
Frequency: 1 affected / 12 at risk